BioBehavioral Diagnostics

ADHD diagnostics firm raises $6.5M; sees applications for pre- and post-brain surgery assessment

A behavioral health diagnostics firm that developed the first attention-deficit/hyperactivity disorder test approved by the U.S. Food and Drug Administration has raised more than $6 million since May as it continues to expand its device into new markets in the U.S and Europe. BioBehavioral Diagnostics Quotient testing device measures motion and attention state to […]

By Stephanie Baum

MedCity Influencers

BioBehavioral Diagnostics CEO Byron Hewett discusses ADHD efforts

We first spoke with Byron Hewett, the CEO of Cambridge, Mass.-based BioBehavioral Diagnostics Co., late last summer, following a $2.5 million funding round that saw the company sell convertible debt securities to a trio of investors. In the interim things changed for us and Hewett and BBDx. We upgraded our office computer and, in the […]

By MassDevice Staff

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.